Quantcast
Last updated on April 17, 2014 at 11:32 EDT

Latest Opioids Stories

2013-08-05 16:26:53

CUPERTINO, Calif., Aug. 5, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the second quarter of 2013. Total revenues were $3.9 million for the three months ended June 30, 2013 as compared to $4.8 million for the three months ended June 30, 2012. Net loss for the three months ended June 30, 2013 was $5.1 million, compared to a net loss of $4.3 million for the same period in 2012. (Logo:...

2013-07-26 08:25:36

CUPERTINO, Calif., July 26, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) second quarter 2013 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Monday, August 5, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2013-06-18 08:30:40

The patent covers the process and preparation of Tapentadol for the treatment of moderate to severe-acute pain NESS ZIONA, Israel, June 18, 2013 /PRNewswire/ -- Mapi Pharma Ltd. (Mapi), developer of complex bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished dosage forms based on selected drug delivery systems, announced today that the company has been granted a United States patent for Tapentadol. Tapentadol is indicated in the US...

2013-04-24 08:29:26

CUPERTINO, Calif., April 24, 2013 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) first quarter 2013 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Thursday, May 2, 2013 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2013-04-22 08:29:17

MORAGA, Calif., April 22, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that David C. Yeomans, Ph.D., Chief Scientist and Founder, as well as the Director of Pain Research at Stanford University School of Medicine, will be presenting at the 2013 BIO International Convention's BIO Business Forum on April 22(nd), 2013 at the McCormick Place in Chicago,...

2013-03-01 16:25:21

SAN FRANCISCO, March 1, 2013 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) Senior Vice President and Chief Medical Officer, Dr. Robert Medve, is scheduled to present at the 33rd Annual Cowen and Company Healthcare Conference at the Boston Marriott Copley Place on Tuesday, March 5, 2013 at 8:00 a.m. Eastern time. The presentation will be accessible via a Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website http://www.nektar.com. This...

2012-10-30 15:23:57

CUPERTINO, Calif., Oct. 30, 2012 /PRNewswire/ -- In conjunction with DURECT Corporation's (Nasdaq: DRRX) third quarter 2012 financial results press release, you are invited to listen to the conference call that will be broadcast live over the internet on Monday, November 5, 2012 at 4:30 pm Eastern Time (1:30 pm Pacific Time). (Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO) A live audio webcast of the presentation will be available by accessing DURECT's homepage at...

2012-10-03 23:03:54

Drug testing was used less frequently in Louisiana than recommended by medical treatment guidelines for chronic opioid management, between 23 and 24 percent of cases with longer-term use of narcotics over the study period from 2007/2009 to 2009/2011. Cambridge, MA (PRWEB) October 02, 2012 With opioid misuse a top public health problem in the United States, a new report by the Workers Compensation Research Institute (WCRI) showed that few physicians in Louisiana were following recommended...

2012-10-03 23:03:50

This report, Longer-Term Use of Opioids, examined longer-term use of narcotics (or opioids) in 21 states and how often recommended medical treatment guidelines for monitoring injured workers with longer-term use were followed by physicians. However, the study found relatively low compliance with the medical treatment guidelines in most states, including New York. Cambridge, MA (PRWEB) October 02, 2012 With opioid misuse a top public health problem in the United States, a new report by the...

2012-10-03 23:03:42

Psychological evaluation in Pennsylvania was rarely used among injured workers with longer-term use of narcotics–only 3-4 percent of the workers received the service over the study period from 2007/2009 to 2009/2011. Cambridge, MA (PRWEB) October 02, 2012 With opioid misuse a top public health problem in the United States, a new report by the Workers Compensation Research Institute (WCRI) showed that few physicians in Pennsylvania were following recommended medical treatment...